Dmytro Zhylko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dmytro Zhylko has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Adam Kania
GSK.ai
1 shared publication - Andriy Zhylko
Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland
1 shared publication - Andrzej Siódmok
Jagiellonian University
1 shared publication - Anya Wyporski
Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland
1 shared publication - Barbara Górnicka
Department of Pathology, Medical University of Warsaw, Warsaw, Poland
1 shared publication Barbara Lawrenz
ART Fertility Clinics
1 shared publication
Latest Publications
- Open Access
- 13 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 471
Real-Time Biomarkers of Liver Graft Quality in Hypothermic Oxygenated Machine Perfusion
Background: Hypothermic oxygenated machine perfusion has emerged as a strategy to alleviate ischemic-reperfusion injury in liver grafts. Nevertheless, there is limited data on the effectiveness of hypothermic liver perfusion in evaluating organ quality. This study aimed to introduce a readily accessible real-time predictive biomarker measured in machine perfusate for post-transplant liver graft function. Methods: The study evaluated perfusate analytes over a 90-day postoperative period in 26 patients randomly assigned to receive a liver graft following dual hypothermic machine perfusion in a prospective randomized controlled trial. Machine perfusion was consistently conducted end-ischemically for at least 120 min, with real-time perfusate assessment at 30-min intervals. Graft functionality was assessed using established metrics, including Early Allograft Dysfunction (EAD). Results: Perfusate lactate concentration after 120 min of machine perfusion demonstrated significant predictive value for EAD (AUC ROC: 0.841, p = 0.009). Additionally, it correlated with post-transplant peak transaminase levels and extended hospital stays. Subgroup analysis revealed significantly higher lactate accumulation in livers with post-transplant EAD. Conclusions: Liver graft quality can be effectively assessed during hypothermic machine perfusion using simple perfusate lactate measurements. The reliability and accessibility of this evaluation support its potential integration into diverse transplant centers.
- 13 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 471
Open AccessReal-Time Biomarkers of Liver Graft Quality in Hypothermic Oxygenated Machine Perfusion
Background: Hypothermic oxygenated machine perfusion has emerged as a strategy to alleviate ischemic-reperfusion injury in liver grafts. Nevertheless, there is limited data on the effectiveness of hypothermic liver perfusion in evaluating organ quality. This study aimed to introduce a readily accessible real-time predictive biomarker measured in machine perfusate for post-transplant liver graft function. Methods: The study evaluated perfusate analytes over a 90-day postoperative period in 26 patients randomly assigned to receive a liver graft following dual hypothermic machine perfusion in a prospective randomized controlled trial. Machine perfusion was consistently conducted end-ischemically for at least 120 min, with real-time perfusate assessment at 30-min intervals. Graft functionality was assessed using established metrics, including Early Allograft Dysfunction (EAD). Results: Perfusate lactate concentration after 120 min of machine perfusion demonstrated significant predictive value for EAD (AUC ROC: 0.841, p = 0.009). Additionally, it correlated with post-transplant peak transaminase levels and extended hospital stays. Subgroup analysis revealed significantly higher lactate accumulation in livers with post-transplant EAD. Conclusions: Liver graft quality can be effectively assessed during hypothermic machine perfusion using simple perfusate lactate measurements. The reliability and accessibility of this evaluation support its potential integration into diverse transplant centers.
- Open Access
Assisted Reproductive Technology Dataset of Embryo Time-lapse Images and Clinical Data
In this report, we present Version 1.0 of the Assisted Reproductive Technology (ART) Dataset, a multi-modal fertility dataset from treatments performed at the ART Fertility Clinic in Abu Dhabi, United Arab Emirates, between 2015 and 2022. The data consists of Electronic Health Records (EHR) and embryo development image sequences captured with the Vitrolife EmbryoScope time-lapse system, providing detailed treatment, morphology, and pregnancy outcome information. The final processed dataset consists of a total of 14,776 embryos from 1,810 patients across 2,500 treatments. This dataset will be used in the development of machine learning models for automated analysis of embryo development and viability, to assist clinical decision-making. This report provides a summary of the statistics of the dataset, as well as the extraction and pre-processing pipelines of the time-lapse images and EHR data. The dataset is private, so we publish this report for transparency on data pre-processing pipelines to share the methodology with similar studies that may arise.
Open AccessAssisted Reproductive Technology Dataset of Embryo Time-lapse Images and Clinical Data
In this report, we present Version 1.0 of the Assisted Reproductive Technology (ART) Dataset, a multi-modal fertility dataset from treatments performed at the ART Fertility Clinic in Abu Dhabi, United Arab Emirates, between 2015 and 2022. The data consists of Electronic Health Records (EHR) and embryo development image sequences captured with the Vitrolife EmbryoScope time-lapse system, providing detailed treatment, morphology, and pregnancy outcome information. The final processed dataset consists of a total of 14,776 embryos from 1,810 patients across 2,500 treatments. This dataset will be used in the development of machine learning models for automated analysis of embryo development and viability, to assist clinical decision-making. This report provides a summary of the statistics of the dataset, as well as the extraction and pre-processing pipelines of the time-lapse images and EHR data. The dataset is private, so we publish this report for transparency on data pre-processing pipelines to share the methodology with similar studies that may arise.